Interaction of natural dietary and herbal anionic compounds and flavonoids with human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Li ^a   Sweet, Douglas H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHIN; CYNARINE; EPICATECHIN; GLYCYRRHETINIC ACID; MYCOPHENOLIC ACID; NATURAL PRODUCT; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER 4; URSOLIC ACID;

ANIMAL CELL; ARTICLE; DOSE RESPONSE; FEMALE; NONHUMAN; PRIORITY JOURNAL;

EID: 84876591247     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/612527     Document Type: Article

References (33)

1. Wang L., Sweet D. H., Renal organic anion transporters (SLC22 Family): expression, regulation, roles in toxicity, and impact on injury and disease. The AAPS Journal 2013 15 69 53 69 10.1208/s12248-012-9413-y
2. VanWert A. L., Gionfriddo M. R., Sweet D. H., Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology. Biopharmaceutics and Drug Disposition 2010 31 1 1 71 2-s2.0-75349105185 10.1002/bdd.693
3. Whitley A. C., Sweet D. H., Walle T., The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1. Drug Metabolism and Disposition 2005 33 8 1097 1100 2-s2.0-22944481531 10.1124/dmd.105.004275 (Pubitemid 41043750)
4. Wong C. C., Botting N. P., Orfila C., Al-Maharik N., Williamson G., Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6). Biochemical Pharmacology 2011 81 7 942 949 2-s2.0-79952575127 10.1016/j.bcp.2011.01.004
5. Wang L., Sweet D. H., Active hydrophilic components of the medicinal herb Salvia miltiorrhiza (Danshen) potently inhibit organic anion transporters 1 (Slc22a6) and 3 (Slc22a8). Evidence-Based Complementary and Alternative Medicine 2012 2012 8 872458 10.1155/2012/872458
6. Wang L., Sweet D. H., Potential for food-drug interactions by dietary phenolic acids on human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11). Biochemical Pharmacology 2012 84 8 1088 1095 10.1016/j.bcp.2012. 07.027
7. Renouf M., Redeuil K., Longet K., Marmet C., Dionisi F., Kussmann M., Williamson G., Nagy K., Plasma pharmacokinetics of catechin metabolite 4′ -O-Me-EGC in healthy humans. European Journal of Nutrition 2011 50 7 575 580 10.1007/s00394-010-0164-1
8. Chow H. H., Hakim I. A., Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacological Research 2011 64 105 112
9. Schram K., Miketova P., Slanina J., Humpa O., Taborska E., Mass spectrometry of 1,3- and 1,5-dicaffeoylquinic acids. Journal of Mass Spectrometry 2004 39 4 384 395 2-s2.0-1942516860 10.1002/jms.600 (Pubitemid 38515352)
10. King P. J., Ma G., Miao W., Jia Q., McDougall B. R., Reinecke M. G., Cornell C., Kuan J., Kim T. R., Robinson W. E., Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication. Journal of Medicinal Chemistry 1999 42 3 497 509 2-s2.0-0032972042 10.1021/jm9804735 (Pubitemid 29085110)
11. Mahadevan S., Park Y., Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. Journal of Food Science 2008 73 1 R14 R19 2-s2.0-38349102172 10.1111/j.1750-3841.2007.00597.x
12. Zou Q., Wei P., Li J., Ge Z. X., Ouyang P., Simultaneous determination of 18 α-and 18 β -glycyrrhetic acid in human plasma by LC-ESI-MS and its application to pharmacokinetics. Biomedical Chromatography 2009 23 1 54 62 2-s2.0-59949098044 10.1002/bmc.1082
13. Xia Y., Wei G., Si D., Liu C., Quantitation of ursolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry and its pharmacokinetic study. Journal of Chromatography B 2011 879 2 219 224 2-s2.0-78651252487 10.1016/j.jchromb.2010.11.037
14. VanWert A. L., Srimaroeng C., Sweet D. H., Organic anion transporter 3 (Oat3/Slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin. Molecular Pharmacology 2008 74 1 122 131 2-s2.0-45749158039 10.1124/mol.107.042853 (Pubitemid 351872164)
15. Ho E. S., Lin D. C., Mendel D. B., Cihlar T., Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. Journal of the American Society of Nephrology 2000 11 3 383 393 2-s2.0-0034008388 (Pubitemid 30115068)
16. Zhou F., Xu W., Hong M., Pan Z., Sinko P. J., Ma J., You G., The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4. Molecular Pharmacology 2005 67 3 868 876 2-s2.0-14944353459 10.1124/mol.104.007583 (Pubitemid 40365334)
17. Schnabolk G. W., Gupta B., Mulgaonkar A., Kulkarni M., Sweet D. H., Organic anion transporter 6 (Slc22a20) specificity and sertoli cell-specific expression provide new insight on potential endogenous roles. Journal of Pharmacology and Experimental Therapeutics 2010 334 3 927 935 2-s2.0-77956237495 10.1124/jpet.110.168765
18. Uwai Y., Ozeki Y., Isaka T., Honjo H., Iwamoto K., Inhibitory effect of caffeic acid on human organic anion transporters hOAT1 and hOAT3: a novel candidate for food-drug interaction. Drug Metabolism and Pharmacokinetics 2011 26 486 493 10.2133/dmpk.DMPK-11-RG-020
19. Duan P., You G., Novobiocin is a potent inhibitor for human organic anion transporters. Drug Metabolism and Disposition 2009 37 6 1203 1210 2-s2.0-66649135287 10.1124/dmd.109.026880
20. Bakhiya N., Monien B., Frank H., Seidel A., Glatt H., Renal organic anion transporters OAT1 and OAT3 mediate the cellular accumulation of 5-sulfooxymethylfurfural, a reactive, nephrotoxic metabolite of the Maillard product 5-hydroxymethylfurfural. Biochemical Pharmacology 2009 78 4 414 419 2-s2.0-67349206640 10.1016/j.bcp.2009.04.017
21. Jung K. Y., Takeda M., Kim D. K., Tojo A., Narikawa S., Yoo B. S., Hosoyamada M., Cha S. H., Sekine T., Endou H., Characterization of ochratoxin A transport by human organic anion transporters. Life Sciences 2001 69 18 2123 2135 2-s2.0-0035929163 10.1016/S0024-3205(01)01296-6 (Pubitemid 32907580)
22. Wang L., Sweet D. H., Competitive inhibition of human organic anion transporters 1 (SLC22A6), 3 (SLC22A8) and 4 (SLC22A11) by major components of the medicinal herb Salvia miltiorrhiza (Danshen). Drug Metabolism and Pharmacokinetics 2012 10.2133/dmpk.DMPK-12-RG-116
23. Gu R., Dou G., Wang J., Dong J., Meng Z., Simultaneous determination of 1,5-dicaffeoylquinic acid and its active metabolites in human plasma by liquid chromatography-tandem mass spectrometry for pharmacokinetic studies. Journal of Chromatography B 2007 852 1-2 85 91 2-s2.0-34249672360 10.1016/j.jchromb.2006. 12.055 (Pubitemid 46830097)
24. Ploeger B., Mensinga T., Sips A., Seinen W., Meulenbelt J., DeJongh J., The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metabolism Reviews 2001 33 2 125 147 2-s2.0-0034900215 10.1081/DMR-100104400 (Pubitemid 32703253)
25. Ploeger B., Mensinga T., Sips A., Deerenberg C., Meulenbelt J., DeJongh J., A population physiologically based pharmacokinetic/pharmacodynamic model for the inhibition of 11- β -hydroxysteroid dehydrogenase activity by glycyrrhetic acid. Toxicology and Applied Pharmacology 2001 170 1 46 55 2-s2.0-0035148540 10.1006/taap.2000.9078 (Pubitemid 32066386)
26. Bakhiya N., Arlt V. M., Bahn A., Burckhardt G., Phillips D. H., Glatt H., Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy. Toxicology 2009 264 1-2 74 79 2-s2.0-69449105950 10.1016/j.tox.2009.07.014
27. Dickman K. G., Sweet D. H., Bonala R., Ray T., Wu A., Physiological and molecular characterization of aristolochic acid transport by the kidney. Journal of Pharmacology and Experimental Therapeutics 2011 338 2 588 597 2-s2.0-79960527351 10.1124/jpet.111.180984
28. Pedersen J. M., Matsson P., Bergström C. A. S., Norinder U., Hoogstraate J., Artursson P., Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of Medicinal Chemistry 2008 51 11 3275 3287 2-s2.0-44949184483 10.1021/jm7015683 (Pubitemid 351821886)
29. Kindla J., Müller F., Mieth M., Fromm M. F., König J., Influence of non-steroidal anti-inflammatory drugs on Organic Anion Transporting Polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport. Drug Metabolism and Disposition 2011 39 6 1047 1053 2-s2.0-79956099278 10.1124/dmd.110.037622
30. Koenen A., Kock K., Keiser M., Siegmund W., Kroemer H. K., Grube M., Steroid hormones specifically modify the activity of organic anion transporting polypeptides. European Journal of Pharmaceutical Sciences 2012 47 774 780 10.1016/j.ejps.2012.08.017
31. Zhu X., Zhang H., Lo R., Phenolic compounds from the leaf extract of artichoke (Cynara scolymus L.) and their antimicrobial activities. Journal of Agricultural and Food Chemistry 2004 52 24 7272 7278 2-s2.0-9344265790 10.1021/jf0490192
32. Dong G. C., Chuang P. H., Chang K. C., Jan P. S., Hwang P. I., Wu H. B., Yi M., Zhou H. X., Chen H. M., Blocking effect of an immuno-suppressive agent, cynarin, on CD28 of T-cell receptor. Pharmaceutical Research 2009 26 2 375 381 2-s2.0-58549108464 10.1007/s11095-008-9754-5
33. Pellati F., Benvenuti S., Magro L., Melegari M., Soragni F., Analysis of phenolic compounds and radical scavenging activity of Echinacea spp. Journal of Pharmaceutical and Biomedical Analysis 2004 35 2 289 301 2-s2.0-1942439725 10.1016/S0731-7085(03)00645-9 (Pubitemid 38520124)